A Text Messaging Trial to Test Vaping Health Messages Optimized to Young Adults' Vaping Status
Launched by UNIVERSITY OF HAWAII · Jun 17, 2025
Trial Information
Current as of November 05, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This study is looking at whether sending text messages with information about e-cigarettes can help young adults either stop vaping or avoid starting in the first place. The messages will be specially designed based on whether a person currently vapes or is at risk of starting. For example, some messages may come from experts, while others might come from peers, and they will present information in different ways to see what works best. The goal is to find out if these tailored messages can influence vaping habits over six months.
Young adults between 18 and 24 years old who speak English, own a mobile phone, and don’t use tobacco products other than e-cigarettes can take part. Participants will be randomly assigned to receive either the vaping-related messages or unrelated health messages, sent as texts three times a week for six months. They will also be asked to complete surveys and provide saliva samples at four different times to check for nicotine use. This study is not yet recruiting participants but aims to better understand how to support young adults in making healthier choices about vaping.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18-24 years old
- • Fluent in English
- • Not currently using tobacco products other than e-cigarettes at the time of enrollment
- • Have a mobile phone to send and receive text messages
- Exclusion Criteria:
- • Age below 18 or above 24
- • Not being fluent in English
- • Currently using tobacco products other than e-cigarettes
- • Not having a mobile phone
About University Of Hawaii
The University of Hawaii is a leading research institution committed to advancing medical science and improving health outcomes through innovative clinical trials. With a diverse team of experienced researchers and access to a wide range of resources, the university fosters collaborative initiatives that aim to address pressing health challenges. By integrating cutting-edge technology and multidisciplinary expertise, the University of Hawaii conducts rigorous clinical research to enhance understanding of various medical conditions, ultimately contributing to the development of effective therapies and interventions for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Honolulu, Hawaii, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported